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Leaf methanol extract of C. orbiculata L. was investigated for antinociceptive and anti-inﬂammatory activities using acetic acid
writhingandhot-platetestsandcarrageenan-inducedoedematestinmiceandrats,respectively.C.orbiculata(100–400mg/kg,i.p.)
signiﬁcantly inhibited acetic acid-induced writhing and signiﬁcantly delayed the reaction time of mice to the hot-plate-induced
thermal stimulation. Paracetamol (300mg/kg, i.p.) signiﬁcantly inhibited the acetic acid-induced writhing in mice. Morphine
(10mg/kg, i.p.) signiﬁcantly delayed the reaction time of mice to the thermal stimulation produced with hot plate. Leaf methanol
extract of C. orbiculata (50–400mg/kg, i.p.) signiﬁcantly attenuated the carrageenan-induced rat paw oedema. Indomethacin
(10mg/kg, p.o.) also signiﬁcantly attenuated the carrageenan-induced rat paw oedema. The LD50 value obtained for the plant
specieswasgreaterthan4000mg/kg(p.o.).ThedataobtainedindicatethatC.orbiculatahasantinociceptiveandanti-inﬂammatory
activities, justifying the folklore use of the plant species by traditional medicine practitioners in the treatment of painful and
inﬂammatory conditions. The relatively high LD50 obtained shows that C. orbiculata m a yb es a f ei no rn o n t o x i ct om i c e .
1.Introduction
Pain and inﬂammation are some of the most common man-
ifestations of many diseases aﬄicting millions of people
worldwide [1, 2]. Even though there are eﬀective orthodox
medicines used to alleviate these manifestations [3], tradi-
tional medicine practitioners in, mainly, developing coun-
tries have used herbal medicines to treat various ailments
including pain and inﬂammation [4]. The dependence of
the population especially in the rural communities in South
Africa on plant medicines as well as traditional medicine
practitioners for their healthcare needs is cultural. One of
such plants used by traditional medicine practitioners to
treat various ailments is Cotyledon orbiculata L. [5, 6]. It
belongs to the family Crassulaceae. It is a small shrub with
ﬂeshy leaves and widely distributed in Southern Africa. It is
known locally as “Seredile” in Sotho and Tswana, “Plakkie”
in Afrikaans, and “Imphewula” in Xhosa [5, 6]. C. orbiculata
is used in the treatment of various ailments in diﬀerent parts
ofSouthAfrica.Theﬂeshyleaveshavebeenusedtotreatcorn
and warts. The juice of the leaves is used as drops for earache
andtoothacheandashotpoulticeforboilsandinﬂammation
[5–7]. Infusion of the ﬂeshy leaves of C. orbiculata has also
been used by traditional medicines practitioners in South
Africa for the treatment of epilepsy, inﬂammation, and aches
(Oral communication).
According to the literature, very limited evaluation has
been done on the pharmacological activities of the plant
species despite the wide folklore use [8]. This study was,
therefore, intended to investigate the antinociceptive and
anti-inﬂammatoryactivitiesofC.orbiculatainmiceandrats,
respectively.TheacutetoxicityandHPLCstudiesoftheplant
species were also carried out.
2.MaterialsandMethods
2.1. Plant Material. The ﬂeshy leaves of C. orbiculata were
collected from Kirstenbosch National Botanical Garden,
CapeTown,inSeptember,2010.Theplantmaterialwasiden-
tiﬁed by the curator of the Gardens as well as a taxonomist
in the Department of Biodiversity and Conservative Biology,2 Advances in Pharmacological Sciences
University of the Western Cape and the voucher specimen
(COT 25) deposited in the University’s Herbarium.
2.2. Preparation of Plant Extract. The ﬂeshy leaves (10.5kg)
of C. orbiculata were washed with water, sliced into pieces,
and dried in a ventilated oven at 40◦C for 120h. The
dried plant material (640g) was ground into ﬁne powder
using Waring Commercial laboratory blender and passed
through 850µm sieve. For the preparation of the methanol
extract, the dried powder (120g) was extracted in a soxhlet
extractor with methanol for 72h. The methanol ﬁltrate was
evaporated to dryness using a Buchi RE11 rotavapor and
Buchi 461water bath. A yield of 55.4g of crude methanol
extract was obtained and preserved in a dessicator. Fresh
solution of the crude leaf methanol extract was prepared by
dissolving a given quantity of the methanol extract in a small
volume of dimethylsulfoxide (DMSO) and made up to the
appropriate volume with physiological saline. The methanol
solution was administered intraperitoneally (i.p.) to mice
and rats in a volume of 1mL/100g of body weight.
2.3. Animals. Male albino mice bred in the Animal House
of the Discipline of Pharmacology, School of Pharmacy,
University of the Western Cape, South Africa, weighing 18–
30g were used for the antinociceptive activity and acute
toxicity studies. Young adult male Wistar rats, bought from
the University of Cape Town, South Africa, and weighing
160–210g were used for anti-inﬂammatory activity study.
The animals were housed in a quiet laboratory with an
ambient temperature of 22 ± 1◦C and a12h light/12h dark
cycle was maintained. They all had access to food and water
ad libitum. All the animals were fasted for 16h during which
they had access to water prior to the commencement of the
experiments. Each animal was used for one experiment only.
2.4. Drugs and Chemicals. Indomethacin (Sigma Chemical
Co.) was dissolved in a minimum amount of dimethylsul-
foxide (DMSO, Sigma Chemical Co.) and adjusted to the
appropriate volume with physiological saline. Carrageenan
(SigmaChemicalCo.)andmorphinesulphate(Bodene)were
dissolved in physiological saline to an appropriate volume.
Acetic acid (Merck) was dissolved in physiological saline to
an appropriate strength. Paracetamol (Sigma Chemical Co.)
was dissolved in a minimum volume of propylene glycol 400
(BDH, UK) and adjusted to the appropriate volume with
physiological saline. DMSO solution was prepared by dis-
solving an equal amount of DMSO used to dissolve the plant
extract, in an appropriate volume of physiological saline.
Indomethacin was given orally to rats by means of a bulbed
steel needle. Carrageenan was injected into the subplantar
surface of the right hind paws of the rats.
Morphine, acetic acid, and paracetamol were adminis-
tered intraperitoneally (ip) to mice. Fresh drug solutions
were prepared each morning of the experiment. All drugs
were administered in a volume of 1mL/100g of body weight,
while constant volumes of carrageenan, DMSO, physio-
logical saline, and acetic acid were used. Control animals
received equal volume injections of the appropriate vehicles.
The doses and pretreatment times of the leaf methanol
extract of C. orbiculata and standard drugs, indomethacin,
morphine,paracetamol,andthevehicles,physiologicalsaline
and DMSO, were obtained from preliminary studies in our
laboratory.
3.Assessment Pharmacological Activities
3.1. Antinociceptive Activity of Cotyledon orbiculata
3.1.1. Acetic Acid Writhing Test. The methods of Koster et al.
[9] and Williamson et al. [10] were used for the assessment
of the antinociceptive activity of C. orbiculata.M i c ew e r e
used in groups of 8 per dose of plant extract, standard
drug, paracetamol, or DMSO. They were placed singly in a
transparent perspex mouse cage and allowed to acclimatize
to their environment for 30min prior to the commencement
of the experiment. In the control experiment, the animals
were pretreated with 0.25mL of physiological saline (i.p.) for
15minandthengivenintraperitonealinjectionof0.20mLof
3% acetic acid solution, an irritant, used to induce writhing
(pain). The mice were then left for 5min, and the writhes
were counted for the next 20min. A writhe is deﬁned
as contraction of the abdominal muscles accompanied by
elongation of the body and the hind limbs.
In the test experiment, a group of 8 mice were pretreated
for 15min with either the plant extract (i.p.) or the standard
analgesic drug, paracetamol (i.p.), after which they were
injected with 0.20mL of the 3% acetic acid intraperitoneally,
allowed to stand for 5min and then the number of writhes
counted for 20min as for the control experiment. The ex-
periment was repeated with another group of 8 mice pre-
treated with 0.25mL of DMSO solution (i.p.) for 15min,
after which they were injected with 0.20mL of the 3% acetic
acid intraperitoneally, allowed to stand for 5min, and then
the number of writhes counted for 20min. All experiments
were performed in a quite laboratory with an ambient
temperature of 22 ± 1◦C. The ability of the plant extract
to prevent or signiﬁcantly reduced the number of acetic
acid-induced writhes was an indication of an antinociceptive
activity.
3.1.2. Hot-Plate Test. The methods of Williamson et al. [10]
and Eddy and Leimback [11] were used in the hot-plate test
for the antinociceptive activity of C. orbiculata.M i c ew e r e
used in groups of 8 per dose of plant extract, standard drug,
morphine, or DMSO. Control animals were individually
placed in a 21 glass beaker placed on a thermostatically
controlled hot plate (model HC500, Bibby Sterilin Ltd.,
England) set at 50–55◦C, before and 15min after intraperi-
toneal injection of 0.25mL of physiological saline. The pain
threshold is considered to be reached when the animals lift
and lick their paws or attempt to jump out of the beaker.
The time taken for the mice to exhibit these characteristics,
also known as the reaction or response time, was noted
by means of a stopwatch. The animals were tested before
and 15min, 30min, 45min, and 60min after intraperitoneal
injection of 0.25mL of physiological saline. The experimentsAdvances in Pharmacological Sciences 3
were repeated using other groups of animals, which were
tested before and 15min, 30min, 45min, and 60min after
the intraperitoneal administration of either the plant extract,
morphine, or DMSO. All experiments were performed in a
quite laboratory with an ambient temperature of 22 ± 1◦C.
Ac u t o ﬀ time of 60s was used to avoid harm to the mice.
The ability of the plant extract to delay the reaction time was
taken as an indication of an antinociceptive activity.
3.2. Anti-Inﬂammatory Activity of Cotyledon orbiculata
3.2.1. Rat Paw Oedema Test. Modiﬁed method of Will-
iamson et al. [10] and Winter et al. [12] were used to assess
the anti-inﬂammatory activity of C. orbiculata.R a t sw e r e
used in groups of 8 per dose of plant extract, standard
drug, physiological saline, or DMSO. The rats were divided
into ﬁve groups. Rats in Group I (control) were given
0.25mL (i.p.) of physiological saline. Group II rats received
plant extracts (50–400mg/kg, i.p.). Group III rats were
given the standard anti-inﬂammatory drug, indomethacin
(10mg/kg, p.o.), and Group IV rats received 0.25mL (i.p.)
of DMSO (vehicle). Group V rats were untreated. Oedema
or acute inﬂammation was induced in Group I or control
ratspretreatedfor15minwith0.25mL(i.p.) ofphysiological
saline by injecting 0.1mL of carrageenan (1% dissolved in
0.9% saline solution) into the subplantar surface of the
right hind paw. The oedema following the carrageenan
injection was noticeable within 30–40min. The volume of
the right hind paw was measured before and then after
the injection of carrageenan at 30min intervals for 4h by
volume displacement method using plethysmometer (IITC
Life Sciences, USA). Group II rats were pretreated for 15min
with plant extracts intraperitoneally (i.p.), Group II rats for
1h with indomethacin orally (p.o.) and Group IV rats for
15min with DMSO (i.p.) prior to the injection 0.1mL of
carrageenan into the subplantar surface of the right hind
paws of the rats in each group. The experiments were
repeated with the volumes of the rats’ right hind paws
measured before and then after the injection of carrageenan
at 30min intervals for 4h using the plethysmometer. The
volumes of the untreated rats’ right paws were also measured
at 30min intervals for 4h. Oedema was expressed as a mean
increase in paw volume with respect to physiological saline
control. Inhibition was expressed as a percentage increase or
decreaseinoedemavolume.Theabilityoftheplantextractto
inhibitthefootoedemawastakenasanindicationofananti-
inﬂammatory activity. All experiments were performed in a
quite laboratory with an ambient temperature of 22 ±1◦C.
3.2.2. HPLC Analysis. Chromatographic system: Beckman
HPLC system consisting of double pump Programmable
Solvent Module model 126; Diode Array detector Module
model 168; Samsung computer 386 with management Sys-
tem Gold (Gold V601) software supplied by Beckman;
Column, C18 Bondapak 5µm and dimensions (250 ×
4.6mm).
Chromatographic conditions: Mobile phase: solvent A:
1% acetic acid; solvent B: methanol; Mode: gradient; ﬂow
rate, 1min/min; injection volume, 10µL; detector, UV at
350nm. The HPLC operating conditions were programmed
to give the following: 0min, solvent B: 20%; 5min, solvent
B: 40%; 15min, solvent B: 60%; 20min, solvent B: 80% and
27min, solvent B: 20%. The run rate was 30min.
3.2.3. Acute Toxicity Testing. The method described by Lorke
[13] and modiﬁed by Hilaly et al. [14] was used to determine
the median lethal dose (LD50) of the leaf methanol extract.
Mice were fasted for 16h and then randomly divided into
groups of eight mice per cage. Graded doses of the plant
extract (100, 200, 300, 400, 600, 800, 1600, 2000, 2400, 2800,
3200, 3600, and 4000mg/kg) were separately administered
orally by means of a bulbed steel needle to mice in each test
group. The control group was administered with 0.25mL
(p.o.) of physiological saline by means of a bulbed steel
needle. The mice in both the test and control groups were
then allowed free access to food and water and observed for
over 5 days for signs of acute toxicity including death. The
median lethal dose (LD50) of the leaf methanol extract of C.
orbiculata would be calculated if applicable, from a plot of
log dose-response curve which would be constructed for the
plant species.
3.3. Statistical Analysis. The data on the number of writhes
exhibited by the mice and the eﬀect of carrageenan on the
rat’s right hind paw were analysed using one way analy-
sis of variance (ANOVA) followed by Dunnett’s multiple
comparison test (GraphPad Prism, version 5.0, GraphPad
Software, Inc., SanDiego CA p2130, USA) and presented as
mean ±standarderrormean(SEM).P valuesoflessthan5%
(P<0.05) were considered statistically signiﬁcant.
3.4. Ethical Considerations. The experimental protocol used
in this study was approved (07/04/31) by the Ethics Com-
mittee of the University of the Western Cape, Bellville 7535,
SouthAfrica,andconformswiththeUniversity’sRegulations
Act concerning animal experiments.
4. Results
4.1. Pharmacological Activities: Antinociceptive Activity of
Cotyledon orbiculata
4.1.1. Acetic Acid Writhing Test
Eﬀect of Leaf Methanol Extract of Cotyledon orbiculata on
Acetic Acid-Induced Writhing. 0.20mL (i.p.) of 3% acetic
acid produced a substantial number of writhes in control
mice pretreated with 0.25mL (i.p.) of physiological saline.
Leaf methanol extract of C. orbiculata (100–400mg/kg,
i.p.) in a dose-dependent manner, signiﬁcantly reduced the
number of acetic acid-induced writhes. 100 mg/kg (i.p.) of
the plant species reduced the writhes by 51%. 200mg/kg
(i.p.)and400mg/kg(i.p.)ofC.orbiculataproduced67%and
7 6 %r e d u c t i o ni nw r i t h e sp r o d u c e db y0 . 2 0m Lo f3 %a c e t i c
acid in mice, respectively.Similarly, paracetamol (300mg/kg,
i.p.) profoundly reduced the number of writhes elicited by4 Advances in Pharmacological Sciences
0.20mL of 3% acetic acid by 93%. DMSO (0.25mL, i.p.) did
not signiﬁcantly alter the acetic acid-induced writhes in mice
(Table 1).
Eﬀect of Leaf Methanol Extract of Cotyledon orbiculata on
Hot-Plate-Induced Nociception. Mice pretreated with phys-
iological saline reacted to hot-plate thermal stimulation
at 50◦C–55◦C either by lifting and licking their paws or
attempting to jump out of the beaker. This manifestation
occurred within 6.63 ± 0.60sec in the ﬁrst 15min after
intraperitoneal administration of 0.25mL of physiological.
saline and within 2.75 ± 0.31sec, 60min later after the
injection of 0.25mL of physiological saline. Leaf methanol
extract of C. orbiculata (100–200mg/kg, i.p.) signiﬁcantly
delayedthereactiontimesoftheanimalstohot-platethermal
stimulation30minaftertreatment.C.orbiculata(400mg/kg,
i.p.) signiﬁcantly delayed the pain reaction time of the mice
to the hot-plate-induced thermal stimulation over the 1h
period of measurement. Similarly, morphine (10mg/kg, i.p.)
signiﬁcantly delayed the reaction time of the mice to the
hot-plate-induced thermal stimulation over the 1h period
of measurement. DMSO (0.25mL, i.p.) did not signiﬁcantly
alter the reaction time of the mice to the hot-plate-induced
thermal stimulation over the 1h period of measurement
(Table 2).
Eﬀect of Leaf Methanol Extract of C. orbiculata on Car-
rageenan-Induced Right Hind Paw Oedema. Carrageenan
(1%) injected into the subplantar of the right hind paws
of the rats pretreated with physiological saline induced
oedema or acute inﬂammation in the paws within 30–
40min. The oedema reached its maximum intensity 3h after
injection. 50mg/kg (i.p.) of the leaf methanol extract of
C. orbiculata signiﬁcantly reduced the carrageenan-induced
oedema from 60min up to the 4h period of measurement.
C. orbiculata (100–400mg/kg, i.p.) signiﬁcantly reduced
the carrageenan-induced oedema over the 4h period of
measurement. Indomethacin (10mg/kg, p.o.) profoundly
reduced the carrageenan-induced oedema in the right hind
paws of rats over the 4h period of measurement (Table 3).
4.1.2. Acute Toxicity Test. There were no deaths or signs of
acute toxicity observed after oral administration of 100–
4000mg/kg of the leaf methanol extract of Cotyledon orbic-
ulata with the highest dose tested (4000mg/kg, p.o.) being
the no-adverse-eﬀect-level (NOAEL). That is, the LD50 was
probably greater than 4000mg/kg (p.o.) in mice.
4.1.3. HPLC Analysis. The chromatographic spectrum of
the leaf methanol extract of C. orbiculata obtained revealed
major peaks at the following retention times (minutes):
6.983, 10.521, 12.088, 12.838, and 13.342 (Figure 1).
5. Discussion
Inthepresentstudy,theleafmethanolextractofC.orbiculata
signiﬁcantly inhibited the acetic acid-induced writhing and
signiﬁcantly inhibited the nociception produced by hot
Table 1: Eﬀect of leaf methanol extract of Cotyledon orbiculata on
acetic acid-induced writhing in mice.
Treatment
groups
Dose
(mg/kg)
Number of writhes Percentage
reduction (%) Mean ±SEM
PS 0.25mL 28.13 3.92
C. orbiculata
100 13.83∗ 3.17 51
200 9.20∗∗ 3.04 67
400 6.75∗∗∗ 1.97 76
Paracetamol 300 2.10∗∗∗ 0.24 93
DMSO 0.25mL 29.04 2.73 0
∗P < 0.025, ∗∗P < 0.005, ∗∗∗P<0.001 versus 3% acetic acid (0.20mL,
i.p.) control, ANOVA (n = 8). Writhes are expressed as number of counts
per 20 minutes.
PS: physiological saline.
DMSO: dimethylsulfoxide.
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Figure 1: HPLC ﬁngerprint of leaf methanol extract of Cotyledon
orbiculata.
plate. C. orbiculata also signiﬁcantly attenuated carrageenan-
induced rat right hind paw oedema. Satyanarayana et al.
[15] has shown that acetic acid produced writhing or
nociception by stimulating the production of prostaglandin.
Paracetamol, a standard analgesic drug [2], has been shown
to inhibit prostaglandin synthesis in the brain [16]. It
is, therefore, not surprising that paracetamol signiﬁcantly
attenuated acetic acid-induced nociception in this study.
The eﬀect of paracetamol on prostaglandin in relation to
acetic-acid-induced writhes may be direct or indirect. Since
C. orbiculata also attenuated acetic acid-induced writhing,
it is probable that the plant species may be producing
its antinociceptive activity by aﬀecting the prostaglandin
system. Morphine, a standard centrally acting analgesicAdvances in Pharmacological Sciences 5
Table 2: Eﬀect of leaf methanol extract of Cotyledon orbiculata on hot-plate-induced nociception in mice.
Treatment groups Dose (mg/kg)
Response time (s)
0min 15min 30min 45min 60min
PS 0.25mL 4.13 ±0.13 6.63 ±0.60 4.38 ±0.78 3.38 ±0.68 2.75 ±0.31
C. orbiculata
100 6.63 ±0.92 10.25 ±1.46 11.75
∗∗ ±1.07 7.13 ±1.27 5.13 ±0.08
200 6.63 ±0.85 7.38 ±1.08 12.38+ ±1.43 6.88 ±1.57 6.25 ±1.45
400 5.25 ±0.47 19.13
∗ ±5.01 26.63++ ±3.35 22.63+ ±3.41 24.5++ ±2.55
Morphine 10 3.38 ±0.64 26.63++ ±4.83 36.50++ ±6.55 22.88++ ±2.93 16.63++ ±2.07
DMSO 0.25mL 5.00 ±0.76 6.13 ±0.99 3.88 ±0.38 4.75 ±0.86 4.50 ±0.91
∗P<0.05, ∗∗P<0.025, +P<0.02, ++P<0.001 versus physiological saline control, ANOVA (n = 8). The response time in seconds was expressed as Mean ±
SEM.
PS: physiological saline.
DMSO: dimethylsulfoxide.
Table 3: Eﬀect of leaf methanol extract of Cotyledon orbiculata on carrageenan-induced oedema in the right hind paw of rat.
Treatment
group
Dose
(mg/kg)
P a wv o l u m e( m L )( M e a n± SEM)
0 30 60 90 120 150 180 210 240 (min)
UR — 0.11±0.01 0.12 ±0.08 0.10 ±0.03 0.09 ±0.01 0.11 ±0.04 0.11±0.05 0.09 ±0.07 0.10 ±0.03 0.09 ±0.05
PS 0.25mL 0.09±0.04 0.35 ±0.05 0.48 ±0.03 0.52 ±0.02 0.61 ±0.04 0.68 ±0.02 0.72 ±0.01 0.69 ±0.05 0.69 ±0.03
C. orbiculata
50 0.09±0.01 0.29 ±0.01 0.34
∗ ±0.01 0.41
∗ ±0.07 0.50
∗±0.02 0.53
∗±0.01 0.61
∗±0.04 0.59
∗±0.05 0.58
∗±0.03
100 0.08±0.05 0.26
∗±0.01 0.31
∗∗±0.04 0.37
∗∗±0.01 0.38+±0.02 0.36+±0.03 0.36+±0.02 0.33+±0.01 0.36+±0.04
200 0.11±0.03 0.22
∗±0.02 0.26+ ±0.01 0.27+ ±0.01 0.28+±0.04 0.31+±0.02 0.30 ±0.02 0.20+±0.01 0.30+±0.01
400 0.10±0.04 0.19
∗±0.02 0.22+ ±0.01 0.21+ ±0.03 0.21+±0.02 0.20+±0.04 0.22+±0.01 0.19+±0.01 0.19+±0.02
Indomethacin 10 0.11±0.02 0.14+±0.02 0.18+ ±0.04 0.20+ ±0.06 0.19+±0.03 0.18+±0.01 0.17+±0.02 0.16+±0.03 0.15+±0.04
DMSO 0.25mL 0.11±0.03 0.36 ±0.06 0.44 ±0.04 0.53 ±0.07 0.64 ±0.03 0.66 ±0.04 0.70 ±0.02 0.69 ±0.03 0.67 ±0.01
∗P<0.05, ∗∗P<0.025, +P<0.001 versus physiological saline control, ANOVA (n = 8).
UR: untreated rats.
PS: physiological saline.
DMSO: dimethylsuloxide.
drug [3], signiﬁcantly attenuated the thermal stimulation or
nociception produced by the hot plate. C. orbiculata also
signiﬁcantly attenuated the nociception produced by hot
plate. It is probable that the plant species may be acting via
certain central pain receptors to attenuate the nociception
produced by hot plate in this study. According to Koster et
al. [9], Williamson et al. [10] and Eddy and Leimback [11],
acetic acid writhing and hot plate tests are used to evaluate
peripherally and centrally acting analgesic drugs respectively.
In this study, C. orbiculata attenuated both the acetic acid-
induced writhing and the nociception produced by hot plate
which may suggest that the plant species may have both
peripheral and central antinociceptive eﬀect.
Swingle [17] has shown that prostaglandins, histamine,
serotonin, and bradykinin are mediators of diﬀerent phases
of carrageenan-induced oedema. Di Rosa et al. [18], Capasso
et al. [19], and Salvemini et al. [20] have also reported the
involvement of histamine, 5-hydroxytrptamine, bradykinin,
prostaglandin, and nitric oxide in carrageenan-induced paw
oedema. Nag-Chaudhuri et al. [21] in their report on their
work on the anti-inﬂammatory and related actions of Syzy-
gium cuminii seed extract suggested that prostaglandin E1,
histamine, serotonin, and bradykinin mediate carrageenan-
induced rat paw oedema. Indomethacin has been shown
to produce its anti-inﬂammatory eﬀect by inhibiting the
enzyme, cyclooxygenase, thus inhibiting prostaglandin syn-
thesis [22]. It has also been shown that the nonsteroidal
anti-inﬂammatory drugs may antagonize mediators such as
serotonin, bradykinin, and capsaicin [23]s o m eo fw h i c h
have been implicated in carrageenan-induced paw oedema.
It is not surprising that in this study, indomethacin atten-
uated carrageenan-induced rat right hind paw oedema. C.
orbiculata also attenuated the carrageenan-induced rat right
hind paw oedema which may suggest that probably, the plant
species may be aﬀecting a host of mediators to produce its
anti-inﬂammatory eﬀect.
Amabeoku et al. [8] have shown that the leaves of
C. orbiculata contain tannins, saponins, triterpene steroid,
reducing sugar, and cardiac glycosides. Bruneton [24]r e -
ported that saponins have both analgesic and anti-in-
ﬂammatoryproperties.Itispossible,therefore,thatsaponins
may also be contributing to the antinociceptive and anti-
inﬂammatory activities of C. orbiculata in this study. The
HPLC ﬁngerprint of the plant species obtained revealed
major characteristic peaks at the following retention times6 Advances in Pharmacological Sciences
(minutes): 6.983, 10.521, 12.088, 12.838, and13.342. The
acute toxicity test carried out showed that the LD50 value
obtained for C. orbiculata could be greater than 4000mg/kg
(p.o.).
In conclusion, the data obtained show that C. orbiculata
has both antinociceptive and anti-inﬂammatory activities
which may be produced by the plant species inhibiting
various chemical mediators including prostaglandins and
bradykinin. The relatively high LD50 value of 4000mg/kg
(p.o.) obtained for the plant species shows that it may be safe
in or nontoxic to mice. The result obtained justiﬁes the use
of the plant species by traditional medicine practitioners in
South Africa for the treatment of painful conditions such as
headache, earache, toothache, and inﬂammation. However,
more studies are needed to further elucidate the mechanism
of the antinociceptive and anti-inﬂammatory actions of C.
orbiculata.
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